| Literature DB >> 29075365 |
Woong Jin Bae1,2, Guan Qun Zhu2, Sae Woong Choi2, Hyun Cheol Jeong2, Fahad Bashraheel2, Kang Sup Kim2, Su Jin Kim2, Hyuk Jin Cho2, U Syn Ha2, Sung Hoo Hong2, Ji Youl Lee2, Hyun-A Oh3, Hye Cheong Koo3, Do Ram Kim3, Sung Yeoun Hwang3, Sae Woong Kim1,2.
Abstract
The Korean herbal formulation Ojayeonjonghwan is used for improving late-onset hypogonadism (LOH) symptoms such as erectile dysfunction (ED). A previous research suggested that a modified Ojayeonjonghwan (KH-204) could be used as an alternative to the treatment for ED. The pharmacological effects were examined in different conditions, including in vitro and in vivo. We measured the survival rate of TM3 Leydig cells under the oxidative stress condition. The s.c. injection of leuprorelin was used to induce androgen deprivation. We measured serum testosterone levels, oxidative stress, and apoptosis. The results of the treatment by KH-204 (1) preserved TM3 cells from oxidative stress by improving the expression of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1); (2) lowered the expression of transforming growth factor-beta (TGF-β) 1/SMAD; (3) increased the average of serum testosterone in androgen-deprived male rats; (4) kept the activation of spermatogenesis; (5) upgraded the contents of 8-hydroxy-20-deoxyguanosine (8-OHdG) and degraded the contents of superoxide dismutase (SOD); and (6) reduced apoptosis. We studied that KH-204 improved testicular dysfunction in LOH. It is likely, at least in part, to degrade oxidative stress through the Nrf2/HO-1 pathway. These findings may offer credible evidences for the use of new alternative therapies to treat LOH.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29075365 PMCID: PMC5623782 DOI: 10.1155/2017/6024839
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1(a) Protective effect of KH-204 against oxidative stress. (b) Enhanced activation of ERK and Akt by KH-204 after 24 h of treatment. The difference was statistically significant (∗p < 0.05). And the experiments were repeated for three times.
Figure 2Comparison of the expression levels in vitro and in vivo. (a) is TGF-β1/SMAD and Nrf2/HO-1 in vitro, (b) is densitometric analysis relative to β-actin in vitro, (c) is TGF-β1/SMAD and Nrf2/HO-1 in vivo, and (d) is densitometric analysis relative to in vivo. The difference was statistically significant (∗p < 0.05). And the experiments were repeated for three times.
Comparisons of parameters of the testicular health.
| Testicular weight (g) | Epididymal weight (g) | Germinal cell layer thickness ( | Diameter of seminiferous tubules ( | Serum testosterone (ng/ml) | |
|---|---|---|---|---|---|
| Normal control | 1.62 ± 0.19 | 0.68 ± 0.03 | 73.22 ± 6.34 | 297.34 ± 4.33 | 2.48 ± 0.41 |
| Androgen-dep. control | 1.09 ± 0.06∗ | 0.40 ± 0.08∗ | 42.19 ± 2.69∗ | 251.16 ± 3.62∗ | 1.28 ± 0.34∗ |
| Androgen-dep. 200 | 1.15 ± 0.17 | 0.45 ± 0.06 | 52.46 ± 3.92 | 271.31 ± 1.36 | 1.32 ± 0.52 |
| Androgen-dep. 400 | 1.30 ± 0.05∗∗ | 0.59 ± 0.01∗∗ | 69.86 ± 7.10∗∗ | 280.14 ± 8.32∗∗ | 1.72 ± 0.13∗∗ |
Data show the mean ± s.d. analysis of variance test. ∗Significant statistical difference (p < 0.05) compared with the normal control group. ∗∗Significant statistical difference (p < 0.05) compared with the androgen-deprived control group.
Figure 3Histopathological findings of the testicular tissues (haematoxylin and eosin stain) in (a) the normal control group (n = 8, normal conrtol), (b) the androgen-deprived control group (n = 8, Androgen-dep. control), (c) the androgen-deprived 200 mg/kg group (n = 8, Androgen-dep. 200), and (d) the androgen-deprived 400 mg/kg group (n = 8, Androgen-dep. 400). Compared with the normal control group, a narrow germinal cell layer is observed in the androgen-deprived control group. Scale bars shown in each figure represent 100 μm. And the experiments were repeated for three times.
Figure 4Immunoexpression of 3β-HSD (arrow) in Leydig cells of rat testis after treatment. ×400. (a) The normal control group (n = 8, normal control); (b) the androgen-deprived control group (n = 8, Androgen-dep. control); (c) the androgen-deprived 200 mg/kg group (n = 8, Androgen-dep. 200); (d) the androgen-deprived 400 mg/kg group (n = 8, Androgen-dep. 400); and (e) positive rate of 3β-HSD-immunoreactive cells. The difference was statistically significant (∗p < 0.05 and ∗∗p < 0.01). And the experiments were repeated for three times.
Figure 5Comparison of the expression levels of 8-OHdG (a) and SOD (b). The difference was statistically significant (∗p < 0.05) (n = 8, in each group). And the experiments were repeated for three times.
Figure 6Effect of KH-204 on testicular tissue apoptosis by TUNEL assay. The difference was statistically significant (∗p < 0.05 and ∗∗p < 0.01) (n = 8, in each group). And the experiments were repeated for three times.